Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.
Hartman ML, Xu R, Crowe BJ, Robison LL, Erfurth EM, Kleinberg DL, Zimmermann AG, Woodmansee WW, Cutler GB Jr, Chipman JJ, Melmed S; International HypoCCS Advisory Board. Hartman ML, et al. Among authors: kleinberg dl. J Clin Endocrinol Metab. 2013 Mar;98(3):980-8. doi: 10.1210/jc.2012-2684. Epub 2013 Jan 23. J Clin Endocrinol Metab. 2013. PMID: 23345098 Free PMC article.
Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.
Hoffman AR, Kuntze JE, Baptista J, Baum HB, Baumann GP, Biller BM, Clark RV, Cook D, Inzucchi SE, Kleinberg D, Klibanski A, Phillips LS, Ridgway EC, Robbins RJ, Schlechte J, Sharma M, Thorner MO, Vance ML. Hoffman AR, et al. J Clin Endocrinol Metab. 2004 May;89(5):2048-56. doi: 10.1210/jc.2003-030346. J Clin Endocrinol Metab. 2004. PMID: 15126520 Clinical Trial.
Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML. Biller BM, et al. Among authors: kleinberg dl. J Clin Endocrinol Metab. 2002 May;87(5):2067-79. doi: 10.1210/jcem.87.5.8509. J Clin Endocrinol Metab. 2002. PMID: 11994342 Clinical Trial.
Octreotide as primary therapy for acromegaly.
Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL. Newman CB, et al. Among authors: kleinberg dl. J Clin Endocrinol Metab. 1998 Sep;83(9):3034-40. doi: 10.1210/jcem.83.9.5109. J Clin Endocrinol Metab. 1998. PMID: 9745397 Clinical Trial.
Moderate doses of hGH (0.64 mg/d) improve lipids but not cardiovascular function in GH-deficient adults with normal baseline cardiac function.
Newman CB, Frisch KA, Rosenzweig B, Roubenoff R, Rey M, Kidder T, Kong Y, Pursnani A, Sedlis SP, Schwartzbard A, Kleinberg DL. Newman CB, et al. Among authors: kleinberg dl. J Clin Endocrinol Metab. 2011 Jan;96(1):122-32. doi: 10.1210/jc.2010-1204. Epub 2010 Oct 6. J Clin Endocrinol Metab. 2011. PMID: 20926529 Clinical Trial.
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial.
Melmed S, Popovic V, Bidlingmaier M, Mercado M, van der Lely AJ, Biermasz N, Bolanowski M, Coculescu M, Schopohl J, Racz K, Glaser B, Goth M, Greenman Y, Trainer P, Mezosi E, Shimon I, Giustina A, Korbonits M, Bronstein MD, Kleinberg D, Teichman S, Gliko-Kabir I, Mamluk R, Haviv A, Strasburger C. Melmed S, et al. J Clin Endocrinol Metab. 2015 Apr;100(4):1699-708. doi: 10.1210/jc.2014-4113. Epub 2015 Feb 9. J Clin Endocrinol Metab. 2015. PMID: 25664604 Clinical Trial.
99 results